|
WO2008138126A1
|
|
Bicyclic pyrimidine derivatives as calcium channel blockers
|
|
EP2074105A1
|
|
Cyclopropyl-piperazine compounds as calcium channel blockers
|
|
US2010168103A1
|
|
Diaryl piperidine compounds as calcium channel blockers
|
|
CA2653497A1
|
|
Heterocyclic compounds as calcium channel blockers
|
|
EP2007759A1
|
|
Isoxazole derivatives as calcium channel blockers
|
|
CA2603926A1
|
|
Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
|
|
CN101115710A
|
|
Diamine calcium channel blockers
|
|
US2006235050A1
|
|
Diamine calcium channel blockers
|
|
BRPI0515133A
|
|
urea derivatives as calcium channel blockers
|
|
CA2566041A1
|
|
T-type calcium channel splice variant compositions and methods
|
|
US7179895B2
|
|
Rat calcium channel subunits and related probes, cell lines and methods
|
|
US7195893B2
|
|
Nucleic acids encoding α2δ calcium channel subunits and methods for making and using them
|
|
US7507760B2
|
|
N-type calcium channel blockers
|
|
US7270949B2
|
|
Fluorescence based T-type channel assay
|
|
US7186726B2
|
|
Preferentially substituted calcium channel blockers
|
|
US7297504B1
|
|
Methods for identifying agonists and antagonists of human T-type calcium channels
|
